Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Ascendis Pharma Ads (ASND)

Ascendis Pharma Ads (ASND)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 8,474,983
  • Shares Outstanding, K 53,416
  • Annual Sales, $ 14,980 K
  • Annual Income, $ -244,180 K
  • 60-Month Beta 0.82
  • Price/Sales 545.83
  • Price/Cash Flow N/A
  • Price/Book 7.26
Trade ASND with:

Options Overview

Details
  • Implied Volatility 64.12%
  • Historical Volatility 45.63%
  • IV Percentile 85%
  • IV Rank 42.25%
  • IV High 103.92% on 03/16/20
  • IV Low 35.01% on 12/03/20
  • Put/Call Vol Ratio 0.00
  • Today's Volume 12
  • Volume Avg (30-Day) 70
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 8
  • Open Int (30-Day) 375

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate -1.84
  • Number of Estimates 7
  • High Estimate -1.39
  • Low Estimate -2.19
  • Prior Year -1.88
  • Growth Rate Est. (year over year) +2.13%

Price Performance

See More
Period Period Low Period High Performance
1-Month
145.80 +6.29%
on 02/02/21
169.00 -8.30%
on 02/17/21
-0.75 (-0.48%)
since 01/26/21
3-Month
145.80 +6.29%
on 02/02/21
183.98 -15.77%
on 12/14/20
-7.18 (-4.43%)
since 11/25/20
52-Week
92.00 +68.45%
on 03/18/20
183.98 -15.77%
on 12/14/20
+25.21 (+19.43%)
since 02/26/20

Most Recent Stories

More News
Ascendis Pharma A/S Announces New "Outgrow GHD" Educational Resource to Support Rare Disease Day 2021

Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon technologies to address unmet medical needs, today announced the launch of Outgrow GHD, a new online...

ASND : 154.97 (-2.33%)
Ascendis Pharma A/S Announces Participation at SVB Leerink 10th Annual Global Healthcare Conference

Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon(TM) technologies to create product candidates that address unmet medical needs, today announced that...

ASND : 154.97 (-2.33%)
Frazier Healthcare Partners Adds Highly Experienced Investor to Life Sciences Team

Frazier Healthcare Partners announced the planned addition of Albert Cha, M.D., Ph.D. as Managing Partner on the Life Sciences team. He has over 20 years of experience investing in public and private biopharmaceutical...

AGN : 193.02 (+0.02%)
ASND : 154.97 (-2.33%)
KALV : 32.87 (-1.05%)
ACRS : 22.28 (+5.00%)
BHVN : 84.98 (+2.20%)
MNLO : 1.3500 (-2.17%)
SRRA : 14.74 (+1.83%)
BIOD : 0.65 (+6.56%)
New Strong Sell Stocks for January 14th

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today.

ILMN : 439.41 (-1.45%)
RPT : 10.97 (-0.81%)
ASND : 154.97 (-2.33%)
ITMR : 23.29 (+1.22%)
BLI : 61.97 (+0.10%)
New Strong Sell Stocks for January 13th

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today.

TAL : 77.54 (-0.17%)
PLAY : 40.61 (+2.50%)
ASND : 154.97 (-2.33%)
OPGN : 2.29 (-3.38%)
DBVT : 5.35 (-0.19%)
Ascendis Pharma A/S Provides Vision 3x3 Update at 39th Annual J.P. Morgan Healthcare Conference

Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon(TM) technologies to create product candidates that address unmet medical needs, will provide an update...

JPM : 147.17 (-2.65%)
ASND : 154.97 (-2.33%)
VISEN Pharmaceuticals Closes $150 Million Series B Financing to Accelerate the Development and Commercialization of its Innovative Endocrinology Therapies in Greater China

, /PRNewswire/ --

HBMBF : 370.0000 (+1.09%)
ASND : 154.97 (-2.33%)
Ascendis Pharma A/S Announces Equity Investment in VISEN Pharmaceuticals

- Advances Vision 3x3 to extend global clinical and commercial reach -

ASND : 154.97 (-2.33%)
VISEN Pharmaceuticals Receives IND Approval to Initiate Phase 2 Clinical Trial of TransCon ™ CNP in Achondroplasia (ACH) in China

, /PRNewswire/ -- VISEN Pharmaceuticals, a biotech company committed to the treatment of endocrine-related diseases, introducing the world's leading treatment methods and drugs into the market and hoping...

ASND : 154.97 (-2.33%)
Ascendis Pharma A/S Announces Participation in 39th Annual J.P. Morgan Healthcare Conference

Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon(TM) technologies to create product candidates that address unmet medical needs, today announced that...

JPM : 147.17 (-2.65%)
ASND : 154.97 (-2.33%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Ascendis Pharma A/S is a biopharmaceutical company. The company's product pipeline consist of TransCon Human Growth Hormone, TransCon Treprostinil, TransCon Insulin, TransCon Peptide and TransCon Ranibizumab, which are in different clinical stage, for the treatments of hormone deficiency, endocrinology,...

See More

Key Turning Points

3rd Resistance Point 169.19
2nd Resistance Point 164.47
1st Resistance Point 161.56
Last Price 154.97
1st Support Level 153.93
2nd Support Level 149.21
3rd Support Level 146.30

See More

52-Week High 183.98
Last Price 154.97
Fibonacci 61.8% 148.84
Fibonacci 50% 137.99
Fibonacci 38.2% 127.14
52-Week Low 92.00

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar